SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Annual Wellness Visit, Subsequent — Liliʻuokalani — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Liliʻuokalani |
|---|
| Date of birth | 1838-09-02 |
|---|
| Identifiers | MRN HR-ET024-SYN-TD; SSN (made up) 000-24-3086 |
|---|
| Document date | 1917-07-13 |
|---|
| Author | Kealani Morrison-Takeda, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Subsequent annual wellness visit; no new complaints. [S]
History of Present Illness
Liliʻuokalani returns for her subsequent annual wellness visit, four weeks after her three-month stroke review, with two members of her ʻohana whom she asked to join her. She completed the health risk assessment beforehand. She has had no further nosebleeds since she began using a gel and a humidifier, no new neurological symptoms and no falls. She plays the piano every morning and has begun arranging a new song. She takes apixaban twice daily from a pill box and has missed no doses. She asked to talk about what she would want if she had a larger stroke. [S]
| Element | Detail |
|---|
| Visit | Subsequent annual wellness visit |
| Safety events | No falls, emergency visits or hospital stays since the stroke |
| Medicines | Atorvastatin, losartan and apixaban from a pill box; no over-the-counter medicines |
| Active conditions | Minor ischemic stroke, paroxysmal atrial fibrillation and hypertension, all managed |
| Functional status | Independent in all activities and instrumental activities of daily living |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|
| Self-rated health | Good |
| Psychosocial | Lives with members of her household; close ʻohana and community; daily prayer; no loneliness |
| Behavioral | Never smoker; alcohol rarely; walks in her garden daily; less salted fish |
| Activities of daily living | Independent in bathing, dressing, eating, toileting and transfers |
| Instrumental activities of daily living | Manages her medicines, correspondence and music; does not drive; others shop for the household |
| Home safety | Smoke detectors working; handrails on the stairs; bathroom floor slippery when wet |
| Hearing and vision | Hears well; reading glasses; eye examination last year |
| Bladder | No leakage |
| Memory | No concerns from her or her ʻohana |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Negative | Weight stable; tiredness at the end of a long day only |
| Eyes | Negative | No vision change |
| Ears, nose, mouth, and throat | Negative | No further nosebleeds; hearing normal |
| Cardiovascular | Negative | No palpitations, chest pain or swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No black stools or swallowing difficulty |
| Genitourinary | Negative | No blood in the urine |
| Musculoskeletal | Negative | No falls; mild stiffness of the knees |
| Integumentary | Negative | Occasional small bruises on the forearms |
| Neurological | Negative | No weakness, numbness, speech or vision change; right hand normal at the piano |
| Psychiatric | Negative | Mood steady; PHQ-2 score 0 |
| Hematologic | Negative | No bleeding gums |
12 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily for 21 days, after a 325 mg loading dose in the emergency department | One tablet daily for 21 days | Oral route | 1917-03-16 to 1917-04-06 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet daily, after a 300 mg loading dose in the emergency department | One tablet daily | Oral route | 1917-03-16 to 1917-04-20 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1917-03-16 | active | S |
| Losartan 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1917-03-23 | active | S |
| Apixaban 5 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 1917-04-20 | active | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1917-07-13 | Body height | 160 | cm | S |
| 1917-07-13 | Body weight | 57.6 | kg | S |
| 1917-07-13 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1917-07-13 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1917-07-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1917-07-13 | Heart rate | 68 | /min | S |
| 1917-07-13 | Respiratory rate | 16 | /min | S |
| 1917-07-13 | Body temperature | 36.6 | Cel | S |
| 1917-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1917-07-13 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | | | S |
| 1917-07-13 | Total score [Mini-Cog] | 5 | {score} | | | S |
| 1917-07-13 | Total score [AUDIT-C] | 1 | {score} | | | S |
Physical Exam
Vital signs recorded on 1917-07-13; see the Vital Signs section. [S]
| System | Finding |
|---|
| Constitutional | Alert, well and composed; blood pressure 124/72, pulse 68 and regular |
| Eyes | Pupils equal and reactive; near vision 20/30 with reading glasses |
| Ears | Whispered-voice test passed on both sides |
| Neck | No carotid bruits |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Musculoskeletal | Timed Up and Go 11 seconds; steady gait; rises from a chair without using her arms |
| Neurological | Oriented; Mini-Cog 5 of 5; speech fluent; normal strength and fine movements of the right hand |
| Skin | Two small bruises on the left forearm; no suspicious lesions |
| Psychiatric | Calm, engaged and warm |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Transient weakness and clumsiness of the right hand with word-finding difficulty, lasting about 20 minutes and fully resolved, the afternoon before the visit; suspected transient ischemic attack, ABCD2 score 5 (high risk); NIH Stroke Scale 0 | resolved | provisional |
G45.9 | S — Synthetic presenting problem; resolved into the stroke diagnosis when diffusion MRI showed a small infarct at the stroke clinic the next day. Not a claim about her real symptoms. |
| Minor ischemic stroke: a small acute infarct in the cortex of the left precentral gyrus (left middle cerebral artery territory) on diffusion MRI, embolic in pattern, with full recovery (NIH Stroke Scale 0); source found to be paroxysmal atrial fibrillation; synthetic modern episode linked to her documented death from a stroke | active | confirmed |
I63.412 | S — Synthetic modern diagnosis made at the stroke clinic the day after the visit; the 1917 cause of death remains D. |
| Hypertension: told of borderline readings in past years and not treated; 156/88 mmHg at intake | active | confirmed |
I10 | S — Synthetic risk factor; no blood pressure from her lifetime is recorded in the cited sources. |
| Paroxysmal atrial fibrillation found on 30-day ambulatory monitoring after the stroke (six episodes, the longest 3 hours 10 minutes; burden about 3%); CHA2DS2-VASc 6, HAS-BLED 2 | active | confirmed |
I48.0 | S — Synthetic finding on prolonged rhythm monitoring at five weeks. |
| Anterior nosebleed from the left side of the nasal septum four weeks after starting apixaban, stopped with pressure; hemoglobin unchanged; resolved | resolved | confirmed |
R04.0 | S — Synthetic intercurrent problem at an unscheduled visit; a common minor bleed on an anticoagulant, not a documented illness. |
Assessment and Plan
- Subsequent annual wellness visit completed. Health risk assessment reviewed, personalized prevention plan updated and a written copy given. Depression, alcohol and cognitive screens are negative; fall risk is moderate because she takes an anticoagulant. [S]
- Next annual wellness visit in one year.
- Minor ischemic stroke (I63.412). No recurrence; full recovery of the right hand and speech. [S]
- Continue atorvastatin, losartan and apixaban.
- Five-month review in six weeks with a lipid panel, kidney function and a blood count.
- Fall risk on an anticoagulant. No falls and a Timed Up and Go of 11 seconds, but a fall on apixaban could cause a serious bleed. [S]
- Non-slip mat and a grab bar in the bathroom.
- Balance and strength exercises from the falls-prevention program at the community center.
- Call the clinic after any fall, and go to the emergency department after any blow to the head.
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|
| Pneumococcal vaccine | Completed today | PCV20 today; no prior pneumococcal vaccine |
| RSV vaccine | Completed today | Single dose today, for adults 75 and older |
| Influenza vaccine | Due | This season's high-dose vaccine when it arrives in the autumn |
| COVID-19 vaccine | Due | This season's vaccine in the autumn |
| Recombinant zoster vaccine | Due | Never given; first dose at the five-month review |
| Tetanus booster | Due | No record within ten years; Tdap at the five-month review |
| Bone density (DXA) | Ordered | Osteopenia on a scan three years ago; repeat now because a fracture on an anticoagulant carries extra risk |
| Hepatitis C screening | Ordered | One-time screening for adults 18 to 79; never tested; blood drawn today, result by telephone |
| Breast cancer screening | Not indicated | Evidence is insufficient after 75; after discussion she chose to stop mammograms |
| Colorectal cancer screening | Not indicated | Normal colonoscopy at 70; at 76 to 85 screening is selective, and after discussion she chose not to continue |
| Cervical cancer screening | Not indicated | Not recommended after 65 with adequate prior screening |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker; aneurysm screening applies to men who have smoked |
| Depression screening | Completed today | PHQ-2 score 0 |
| Alcohol misuse screening | Completed today | AUDIT-C score 1 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5; MoCA 26 at the stroke clinic |
| Falls prevention | Completed today | Timed Up and Go 11 seconds; bathroom safety and an exercise program |
| Blood pressure, cholesterol and diabetes screening | Up to date | Blood pressure at every visit; LDL 64 mg/dL at the five-week review; hemoglobin A1c 5.5% at intake |
Immunizations given today: Pneumococcal conjugate vaccine PCV20; Respiratory syncytial virus vaccine, single dose [S]
Follow-up: DXA booked; hepatitis C result by telephone. Five-month review in six weeks. Influenza and COVID-19 vaccines in the autumn. Next annual wellness visit in one year. Next scheduled visit 1917-08-24: five-month review: blood pressure, lipids, apixaban safety, cognition and plans for the months ahead. [S]
Advance Care Planning
Voluntary advance care planning discussion of about 25 minutes, with her consent and with the two members of her ʻohana she invited. She named one of them, whom she raised as hānai, as her health care agent on the Hawaiʻi advance health care directive, now copied into the chart. She wants full treatment for a stroke or illness she could recover from, including clot-removal treatment if it were offered in time. If a severe stroke left her unable to speak, understand or know her ʻohana, with little hope of recovery, she would not want resuscitation, a breathing machine or tube feeding, and would want to be cared for at home in comfort, with her ʻohana and her minister with her and with her own Hawaiian practices as she and her ʻohana choose. She asked that her agent make decisions together with the ʻohana, while respecting what she has said today. [S]